Search Results - "Hetzel, Gerd R"
-
1
Filtration of Macrophage Migration Inhibitory Factor (MIF) in Patients with End Stage Renal Disease Undergoing Hemodialysis
Published in PloS one (20-10-2015)“…End stage renal disease (ESRD) patients are characterized by increased morbidity and mortality due to highest prevalence of cardiovascular disease. Macrophage…”
Get full text
Journal Article -
2
Indicators of acute and persistent renal damage in adult thrombotic microangiopathy
Published in PloS one (23-01-2012)“…Thrombotic microangiopathies (TMA) in adults such as thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are life-threatening…”
Get full text
Journal Article -
3
Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled Trial
Published in Clinical journal of the American Society of Nephrology (07-01-2016)“…Hemodialysis (HD) per se entails vascular dysfunction in patients with ESRD. Endothelial dysfunction is a key step in atherosclerosis and is characterized by…”
Get full text
Journal Article -
4
Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial
Published in Nephrology, dialysis, transplantation (01-01-2011)“…Continuous venovenous haemofiltration (CVVH) in the intensive care setting requires anticoagulation to prevent clotting of the extracorporeal circuit. Several…”
Get full text
Journal Article -
5
Macrophage migration inhibitory factor is associated with vascular dysfunction in patients with end-stage renal disease
Published in International journal of cardiology (15-10-2013)“…Abstract Background Patients with end-stage renal disease (ESRD) show a high prevalence of cardiovascular disease with arterial stiffness, atherosclerosis and…”
Get full text
Journal Article -
6
Citrate Plasma Levels in Patients Under Regional Anticoagulation in Continuous Venovenous Hemofiltration
Published in American journal of kidney diseases (01-11-2006)“…Background: Different methods of regional anticoagulation using citrate in continuous hemofiltration have been described. To date, only such surrogate…”
Get full text
Journal Article -
7
Monitoring oral anticoagulation may require determination of single coagulation factor activities in patients with antiphospholipid syndrome
Published in Journal of rheumatology (01-09-2006)“…We describe a 32-year-old man with secondary antiphospholipid syndrome (APS) who received oral anticoagulation with phenprocoumon after deep vein thrombosis…”
Get full text
Journal Article -
8
Prevalence and risk factors of pre-diabetes after renal transplantation: a single-centre cohort study in 200 consecutive patients
Published in Nephrology, dialysis, transplantation (01-08-2012)“…After renal transplantation, patients are prone to develop impairments in glucose metabolism. In 2005, the American Diabetes Association published new…”
Get full text
Journal Article -
9
The heparins: all a nephrologist should know
Published in Nephrology, dialysis, transplantation (01-10-2005)Get full text
Journal Article -
10
Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders
Published in Archives of neurology (Chicago) (01-07-2006)“…Plasma exchange is a well-established therapeutic procedure commonly used in many neurological disorders of autoimmune etiology. It is thought that the…”
Get more information
Journal Article -
11
Are prothrombotic variants of platelet glycoprotein receptor polymorphisms involved in the pathogenesis of thrombotic microangiopathies?
Published in Clinical and applied thrombosis/hemostasis (01-08-2009)“…Thrombotic microangiopathies are life-threatening disorders characterized by vascular microthromboses, schistocytic hemolytic anemia, and thrombocytopenia…”
Get more information
Journal Article -
12
The G1691A mutation of the factor V gene (factor V Leiden) and the G20210A mutation of the prothrombin gene as risk factors in thrombotic microangiopathies
Published in Clinical and applied thrombosis/hemostasis (01-06-2009)“…Factor V Leiden (FVL) mutation and prothrombin G20210A mutation are common hereditary risk factors for venous thrombosis. In the current study, 40 patients…”
Get more information
Journal Article -
13
The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies
Published in Clinical and applied thrombosis/hemostasis (01-04-2009)“…The 34 Leu (100T) variant of the factor XIII Val34Leu (G100T-) polymorphism slows down fibrinolysis and has been proposed as a thrombotic risk factor. In this…”
Get more information
Journal Article -
14
Effects of candesartan on glomerular hemodynamics and permselectivity in patients with favorable renal allograft function
Published in Transplantation (27-03-2005)“…Distinct effects of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers on glomerular perfusion and permselectivity are important…”
Get full text
Journal Article -
15
The TT genotype of the C677T polymorphism in the methylentetrahydrofolate reductase as a risk factor in thrombotic microangiopathies: results from a pilot study
Published in Clinical and applied thrombosis/hemostasis (01-06-2009)“…In this study, we assessed the potential role of the TT genotype of the gene of the methylenetetrahydrofolate reductase for the manifestation of thrombotic…”
Get more information
Journal Article -
16
Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders
Published in Archives of neurology (Chicago) (01-08-2006)“…Plasma exchange is a well-established therapeutic procedure commonly used in many neurological disorders of autoimmune etiology. In this second part of our…”
Get more information
Journal Article -
17
Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial
Published in Clinical kidney journal (01-12-2022)“…Background Cardiovascular calcifications are prevented by matrix Gla protein (MGP), a vitamin K–dependent protein. Haemodialysis patients exhibit marked…”
Get full text
Journal Article -
18
Filtration of Macrophage Migration Inhibitory Factor
Published in PloS one (20-10-2015)“…Background End stage renal disease (ESRD) patients are characterized by increased morbidity and mortality due to highest prevalence of cardiovascular disease…”
Get full text
Journal Article -
19
Filtration of Macrophage Migration Inhibitory Factor (MIF) in Patients with End Stage Renal Disease Undergoing Hemodialysis: e0140215
Published in PloS one (01-10-2015)“…Background End stage renal disease (ESRD) patients are characterized by increased morbidity and mortality due to highest prevalence of cardiovascular disease…”
Get full text
Journal Article -
20
The C1542G and G505A Polymorphisms of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Thrombotic Microangiopathies
Published in Blood (16-11-2005)“…Background Thrombotic microangiopathies are characterized by vascular microthromboses, microangiopathic hemolytic anemia, and thrombocytopenia. Although recent…”
Get full text
Journal Article